Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, pressure amplitude and contrast dose
- 1 September 2003
- journal article
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 29 (9) , 1341-1349
- https://doi.org/10.1016/s0301-5629(03)00988-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bioeffects of Myocardial Contrast Microbubble Destruction by EchocardiographyEchocardiography, 2002
- Destruction of Contrast Microbubbles by UltrasoundCirculation, 2001
- Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images∗∗A list of participating investigators appears in the Appendix.The American Journal of Cardiology, 2000
- Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agentJournal of the American College of Cardiology, 1998
- Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiogramsJournal of the American College of Cardiology, 1998
- Benefits of reducing the cardiac cycle–triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imagingJournal of the American Society of Echocardiography, 1997
- Ultrasound contrast agents: A reviewUltrasound in Medicine & Biology, 1994
- Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical resultsJournal of the American College of Cardiology, 1990
- Detection and exclusion of interatrial shunts by two-dimensional echocardiography and peripheral venous injection.Circulation, 1979
- Echocardiography of the Aortic RootInvestigative Radiology, 1968